Cargando…

miR-503 Is Involved in the Protective Effect of Phase II Enzyme Inducer (CPDT) in Diabetic Cardiomyopathy via Nrf2/ARE Signaling Pathway

Diabetic cardiomyopathy (DCM) is a common heart disease. The Phase II enzyme inducer (CPDT) is a complex enzyme that promotes the expression of antioxidant enzymes through activating nuclear factor erythroid 2-related factor 2 (Nrf2); these compounds have been shown to protect against oxidative stre...

Descripción completa

Detalles Bibliográficos
Autores principales:	Miao, Ying, Wan, Qin, Liu, Xiaoyu, Wang, Yu, Luo, Yi, Liu, Dan, Lin, Nengbo, Zhou, Honggang, Zhong, Jiyuan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2017
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5748299/ https://www.ncbi.nlm.nih.gov/pubmed/29404371 http://dx.doi.org/10.1155/2017/9167450

Ejemplares similares

circNRIP1 facilitates keloid progression via FXR1-mediated upregulation of miR-503-3p and miR-503-5p
por: Wang, Baolin, et al.
Publicado: (2021)

Artesunate inhibits osteoclastogenesis through the miR-503/RANK axis
por: Huang, Ming-Zhi, et al.
Publicado: (2020)

Circ_0003266 sponges miR-503-5p to suppress colorectal cancer progression via regulating PDCD4 expression
por: Wen, Caihong, et al.
Publicado: (2021)

MiR-424/503-Mediated Rictor Upregulation Promotes Tumor Progression
por: Oneyama, Chitose, et al.
Publicado: (2013)

TNF Signaling Acts Downstream of MiR-322/-503 in Regulating DM1 Myogenesis
por: Li, Meng, et al.
Publicado: (2022)

LncRNA MIR503HG Promotes High-Glucose-Induced Proximal Tubular Cell Apoptosis by Targeting miR-503-5p/Bcl-2 Pathway
por: Cao, Xu, et al.
Publicado: (2020)

Can MiR-503 be used as a marker in diabetic patients with ischemic stroke?
por: Sheikhbahaei, Saba, et al.
Publicado: (2019)

The Causes and Consequences of miR-503 Dysregulation and Its Impact on Cardiovascular Disease and Cancer
por: He, Yanjing, et al.
Publicado: (2021)

Effect of miR-503 Down-Regulation on Growth and Invasion of Esophagus Carcinoma and Related Immune Function
por: Zhao, Ke, et al.
Publicado: (2015)

The miR-424(322)/503 cluster orchestrates remodeling of the epithelium in the involuting mammary gland
por: Llobet-Navas, David, et al.
Publicado: (2014)

miR-503-5p confers drug resistance by targeting PUMA in colorectal carcinoma
por: Xu, Ke, et al.
Publicado: (2017)

H19X‐encoded miR‐322(424)/miR‐503 regulates muscle mass by targeting translation initiation factors
por: Liang, Rui, et al.
Publicado: (2021)

Mesenchymal stem cells shuttling miR-503 via extracellular vesicles enhance glioma immune escape
por: Wang, Xiao-Song, et al.
Publicado: (2021)

MiR-503 Promotes Bone Formation in Distraction Osteogenesis through Suppressing Smurf1 Expression
por: Sun, Yuxin, et al.
Publicado: (2017)

LncRNA PVT1 promotes cervical cancer progression by sponging miR-503 to upregulate ARL2 expression
por: Liu, Weiwei, et al.
Publicado: (2021)

MiR‐503 pleiotropically regulates epithelial‐mesenchymal transition and targets PTK7 to control lung cancer metastasis
por: Tsai, Tzu‐Hsiu, et al.
Publicado: (2023)

Downregulation of miR-503 Promotes ESCC Cell Proliferation, Migration, and Invasion by Targeting Cyclin D1
por: Jiang, Lanfang, et al.
Publicado: (2017)

miR-503 Inhibits Proliferation, Migration, And Angiogenesis Of Glioma By Acting On VEGFA Through Targeting LRIG2
por: Sun, Sheng-Li, et al.
Publicado: (2019)

miR-322/-503 rescues myoblast defects in myotonic dystrophy type 1 cell model by targeting CUG repeats
por: Shen, Xiaopeng, et al.
Publicado: (2020)

CircNEK6 promotes the progression of pancreatic ductal adenocarcinoma through targeting miR-503/CCND1 axis
por: Shao, Zhiying, et al.
Publicado: (2023)

miR-503 represses CUG-binding protein 1 translation by recruiting CUGBP1 mRNA to processing bodies
por: Cui, Yu-Hong, et al.
Publicado: (2012)

LncRNA MIR503HG inhibits cell migration and invasion via miR‐103/OLFM4 axis in triple negative breast cancer
por: Fu, Jia, et al.
Publicado: (2019)

LncRNA ZNF503-AS1 promotes RPE differentiation by downregulating ZNF503 expression
por: Chen, Xue, et al.
Publicado: (2017)

TGF-β1-induced miR-503 controls cell growth and apoptosis by targeting PDCD4 in glioblastoma cells
por: Guo, Pin, et al.
Publicado: (2017)

LncRNA DLGAP1-AS2 regulates miR-503/cyclin D1 to promote cell proliferation in non-small cell lung cancer
por: Wang, Lu, et al.
Publicado: (2021)

Effects of IMOD(™) on angiogenesis, miR-503 and CDC25 expression levels in heart tissue of diabetic male rats
por: Ghaffari-Nasab, Arshad, et al.
Publicado: (2018)

Stemness-Attenuating miR-503-3p as a Paracrine Factor to Regulate Growth of Cancer Stem Cells
por: Seo, Minkoo, et al.
Publicado: (2018)

miR-424(322)/503 is a breast cancer tumor suppressor whose loss promotes resistance to chemotherapy
por: Rodriguez-Barrueco, Ruth, et al.
Publicado: (2017)

A PPARγ-dependent miR-424/503-CD40 axis regulates inflammation mediated angiogenesis
por: Lee, Aram, et al.
Publicado: (2017)

Serum miR-503 is a Candidate Biomarker for Differentiating Metabolic Healthy Obesity from Metabolic Unhealthy Obesity
por: Yue, Hai-Qing, et al.
Publicado: (2020)

H19X-encoded miR-424(322)/-503 cluster: emerging roles in cell differentiation, proliferation, plasticity and metabolism
por: Wang, Fan, et al.
Publicado: (2018)

Inhibition of Smurf2 translation by miR-322/503 modulates TGF-β/Smad2 signaling and intestinal epithelial homeostasis
por: Cao, Shan, et al.
Publicado: (2014)

MIR210HG promotes cell proliferation and invasion by regulating miR-503-5p/TRAF4 axis in cervical cancer
por: Wang, Ai-Hong, et al.
Publicado: (2020)

A genome-wide microRNA profiling indicates miR-424-5p and miR-503-5p as regulators of ALK expression in neuroblastoma
por: De Mariano, Marilena, et al.
Publicado: (2017)

LncRNA miR503HG Regulates the Drug Resistance of Recurrent Cervical Squamous Cell Carcinoma Cells by Regulating miR-155/Caspase-3
por: Zhao, Shanshan, et al.
Publicado: (2020)

Poster Sessions 313-503
Publicado: (2004)

MIR503HG silencing promotes endometrial stromal cell progression and metastasis and suppresses apoptosis in adenomyosis by activating the Wnt/β‑catenin pathway via targeting miR‑191
por: Xu, Xiaoping, et al.
Publicado: (2023)

LncRNA miR503HG interacts with miR-31-5p through multiple ways to regulate cancer cell invasion and migration in ovarian cancer
por: Zhu, Ding, et al.
Publicado: (2020)

miR-503 represses human cell proliferation and directly targets the oncogene DDHD2 by non-canonical target pairing
por: Polioudakis, Damon, et al.
Publicado: (2015)

MiR-503 suppresses cell proliferation and invasion of gastric cancer by targeting HMGA2 and inactivating WNT signaling pathway
por: Li, Wenjing, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_r8m0jd4m5bbdbh33rn06lpgg99